Corcept’s relacorilant GRADIENT trial misses primary endpoint
Corcept Therapeutics has shared some results from its Phase III GRADIENT trial for relacorilant – its experimental treatment for Cushing’s…
All articles by Eve Thomas
Eve Thomas
Eve Thomas is a reporter writing across a variety of sectors with a specific focus on thematic intelligence. She has a BA in English Literature from the University of Sheffield and an MSt in English from Oxford University.
-
-
Reeves’ 2024 budget promises life sciences investment
Announcing the UK's Budget yesterday (30 October), Rachel Reeves outlined the Labour Party’s investment plans for research and development (R&D)…
-
mRNA licensing agreements surge 800% amid GSK lawsuits
mRNA-based innovator pharmaceuticals have experienced a massive increase in licensing agreement deal values following success with the technology in Covid-19…
-
MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study
A Phase I/II trial (NCT05603312) with MeiraGTx's AAV-GAD Parkinson’s disease gene therapy has met its primary endpoint. The sham-controlled bridging…
-
As mpox spreads, ‘national governments have a moral responsibility to help’
As the number of mpox-related deaths in the Democratic Republic of Congo (DRC) and neighbouring countries continues to climb, international…
-
What is mpox and how big of a threat is it?
Mostly centred in the Democratic Republic of Congo DRC) and its African neighbours, the current outbreak of mpox has been…
-
Anti-obesity drugs will be 2024’s defining trend
Anti-obesity drugs will be the most impactful trend of 2024, followed by personalised and precision medicine, immuno-oncology (IO) drug development,…
-
Psilocybin effective in treating depression
A new study published in the British Medical Journal found potential in the use of psilocybin to treat depression, with…
-
Psychedelic treatments for mental health: Is there substance behind the hype?
Psychedelic treatments have been considered in the treatment of mental health since the 1950s, following Albert Hofmann’s development of lysergic…
-
Remote Patient Monitoring market will reach $760m by 2030
A new report by GlobalData has found that Remote Patient Monitoring (RPM) devices are a growing sector, expected to be…